Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

The summary for the Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed): The purpose of this Notice of Funding Opportunity (NOFO) is to solicit the development of innovative senescence technologies (SenTecs), or the adaptation of existing technologies focused on identification, characterization and understanding the biological consequences of senescent cell (SnC) heterogeneity in the context of the tissue environments and secretomes to facilitate novel strategies for modulating SnCs in vivo and for predicting the outcomes of targeting SnCs in human aging and in disease conditions. These are five-year, milestone-driven awards consisting of two phases. The first two years constitute the UG3 phase and are focused on SenTec development and demonstration of technology feasibility. The following 3-years is the SenTec application UH3 phase where SenTecs continue to be optimized, refined and validated. In the final year of the UH3 award, SenTecs will undertake a demonstration project conducted in a collaborative effort within SenNet to provide further validation of the proposed SenTec. Applicants are required to submit both UG3 and UH3 projects together when responding to this NOFO. Transition from the UG3 to UH3 phases is not automatic and will occur only after administrative review of each SenTec at the close of Year 2 of the award.
Federal Grant Title: Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-27-007
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.310
CFDA Descriptions: Information not provided
Current Application Deadline: November 23rd, 2026
Original Application Deadline: November 23rd, 2026
Posted Date: October 9th, 2026
Creation Date: October 9th, 2026
Archive Date: January 22nd, 2027
Total Program Funding: $6,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 15
Cost Sharing or Matching: No
Last Updated: October 9th, 2026
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Announcement Contact
Common Fund Cellular Senescence Program
[email protected]
Inbox for the Common Fund Cellular Senescence Program
Similar Government Grants
• Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed)
• Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Prog...
• Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Res...
• Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
• Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (Sen...
• Using Metabolomics to Investigate Biological Pathways and Networks (R01)
• Assay Development for High Throughput Molecular Screening (R21)
• Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
• Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional D...
• Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...
• NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
• Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
• Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com